Meanwhile, mice who were immunized with pCT26-5 and then late depleted of their CD4+ T cells in this experiment showed the similar capacity to control tumor growth as pCT26-5 non-depleted (isotype control) mice. This evidence concerns the gene CD4 and neoplasm.